Results 101 to 110 of about 2,929 (206)

Role of Gastric Acid Suppression Therapy in Erosive Esophagitis: From H2 Receptor Antagonists, Proton Pump Inhibitors, to Potassium-Competitive Acid Blockers [PDF]

Erosive esophagitis (EE) is an inflammation of the esophageal mucosa resulting from gastric and duodenal acid reflux, affecting approximately 55% of gastroesophageal reflux disease (GERD) patients in Indonesia. Effective acid suppression is essential for
Arvant, Anisya Zakiyyahaya, Fauzi, Achmad, Herardi, Ryan, Rinaldi, Ikhwan, Sandra, Sharon, Syam, Ari Fahrial   +5 more
core   +1 more source

Still a dilemma! Are vonoprazan and esomeprazole attenuating the antiplatelet function of clopidogrel when taken concomitantly? A systematic review and meta-analysis

The Egyptian Journal of Internal Medicine
Objective CYP2C19 metabolizes all three drugs—esomeprazole, vonoprazan, and clopidogrel—so it is mostly responsible for their drug interactions. Is this clinically true or just theoretical?
Eman Youssef, Aliaa Gamal, Hagar Youssef
doaj   +1 more source

Effect of Concomitant Use of Polaprezinc and Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication

Gastroenterology Insights
Background: Vonoprazan-based triple therapy has recently been reported as being more effective than proton pump inhibitors for the eradication of Helicobacter pylori (H.
Yuto Suzuki, Yasumi Katayama, Yo Fujimoto, Koji Toyoda, Morio Takahashi, Masaya Tamano   +5 more
doaj   +1 more source

Simultaneous Estimation of Aspirin and Vonoprazan in Pure and Pharmaceutical Dosage Form by UV Spectroscopy [PDF]

A simple, accurate, and precise UV-visible spectrophotometric method was developed for the simultaneous estimation of Aspirin and Vonoprazan in pure and pharmaceutical formulations.
Jonnakuti Madhvilatha, Narendra Kumar Nyola, Niranjan Shishir Mahajan   +2 more
core   +1 more source

Comparative Effectiveness of Vonoprazan Dosing Strategies in Bismuth-Based Quadruple Therapy for Helicobacter pylori Eradication: A Prospective Non-inferiority Cohort Study

The Turkish Journal of Gastroenterology
Background/Aims: Vonoprazan 20 mg twice daily is effective for Helicobacter pylori (H.pylori) eradication, but studies on the efficacy of 20 mg once daily are limited.
Lingling Yan, Rong Lin, Yu Zhang, Shanjing Xu, Xianbin Zhou, Jiali Ma, Lina Fang   +6 more
doaj   +1 more source

Relationships of Proton Pump Inhibitor-Induced Renal Injury with CYP2C19 Polymorphism: A Retrospective Cohort Study [PDF]

Proton pump inhibitors (PPIs) have recently been reported to be linked with nephrotoxicity. PPIs are metabolized mainly or partly by cytochrome P450 2C19 (CYP2C19).
0000-0002-9409-0056, 0000-0002-9409-0056, 0000-0003-4079-707X, 0000-0003-4079-707X, 00378613, 00378613, 10324641, 10324641, 20449870, 20449870, 4010, 4010, 40736980, 40736980, 60865707, 60865707, 674, 674, 675, 675, 7156, 7156, 7867, 7867, 8655, 8655, 8769, 8769, FUKUI, Rika, IKEDA, Yoshito, MORITA, Shin-ya, NAKAGAWA, Yoshihisa, NODA, Satoshi, SAWAYAMA, Yuichi, TERADA, Tomohiro, イケダ, ヨシト, サワヤマ, ユウイチ, テラダ, トモヒロ, ナカガワ, ヨシヒサ, ノダ, サトシ, フクイ, リカ, モリタ, シンヤ, 中川, 義久, 寺田, 智祐, 森田, 真也, 池田, 義人, 澤山, 裕一, 福井, 里佳, 野田, 哲史   +48 more
core   +1 more source

Sex-specific Differences in Response to First-line Helicobacter pylori Eradication Therapy with Vonoprazan, Amoxicillin, and Clarithromycin [PDF]

Background: Although gender medicine has been promoted in medical research and patient care, limited information is available on sex-specific differences in response to first-line Helicobacter pylori eradication therapy.
Kajihara, Yusaku
core   +2 more sources

Ten-day vonoprazan-based versus fourteen-day proton pump inhibitor-based therapy for first-line Helicobacter pylori eradication in China: A meta-analysis of randomized controlled trials

International Journal of Immunopathology and Pharmacology
Background: A shorter treatment duration potentially offers the advantage of reducing adverse events (AEs) and enhancing patient compliance for Helicobacter pylori eradication.
Wenwen Gao, Qian Wang, Xiang Zhang, Lu Wang   +3 more
doaj   +1 more source

Dual Therapies Containing an Antibiotic Plus a Proton Pump Inhibitor or Vonoprazan for Helicobacter pylori Infection: A Systematic Review

Microorganisms
Due to the increasing prevalence of antimicrobial resistance, the efficacy of standard triple therapy for Helicobacter pylori (H. pylori) infection has declined, with eradication rates now falling below 80% in most countries.
Chih-An Shih, Deng-Chyang Wu, Chang-Bih Shie, Ping-I Hsu   +3 more
doaj   +1 more source

Advanced interpenetrating polymer networks for innovative gastroretentive formulations targeting Helicobacter pylori gastric colonization [PDF]

The escalating challenges of Helicobacter pylori-induced gastric complications, driven by rising antibiotic resistance and persistent cancer risks, underscore the demand for innovative therapeutic strategies.
Benito Hernández, Elena, Carbajo Gordillo, Ana I., Díaz Blanco, Manuel Jesús, García Martín, María Gracia, Grosso, Roberto, Paz Bañez, María Violante de   +5 more
core   +1 more source